International Endeavors Corp (IDVV)

[sweet crude]

$2.00 target on IDVV (I think can go much higher)

This makes a great point to sell the more riskier marijuana growers and was involved in getting high, and focus money in ones more on the medical side, smart!

I think $2.00 could be way to low on this. $10?....eh not to sure on that as could be wishful thinking, but i think $3 to $5 is very doable with such a low float, and caliber of team now coming into IDVV

Only matter of time...grab what you can under $1.00 and ride the wave

Foremost a Biotech Firm

The main take away for investors looking to play the marijuana sector is that IDVV isn’t going to be your run of the mill marijuana play, but more in the realm of a ‘biotech research firm’ that conducts a core of its research on the non-psychoactive use of cannabis using a specialized cryo process.

Sell Growers, Buy Medical

Ludlow Research, a small cap equity research firm located in New York City, recently issued a note to their subscribers that investors wanting to invest in the marijuana sector may want to sell the growers, dispensaries, and recreational plays, and focus investment capital more in a diversified basket of companies focused strictly on the medical research side due to potential regulatory risks.

For this reason they have initiated coverage on IDVV based on their new management, low public float, and strict focus on non-psychoactive cannabis research for the treatment of a wide variety of illnesses, with a ‘speculative’ short-term target of around $2.00+ per share.

http://www.wallstreetnewscast.com/idvv-1019/